Clinical Trials on Babesiosis, Human in United Kingdom

Total 2948 results

Imugen
American National Red Cross; Memorial Blood Centers, Minnesota; Rhode Island...

Completed

Babesia Testing in Blood Donors

Transfusion Transmitted Babesiosis

United States
Alios Biopharma Inc.

Completed

A Drug-Drug Interaction Study to Evaluate the Effect of AL-794 on the Pharmacokinetics of Oseltamivir and JNJ-63623872

Influenza in Humans

United Kingdom
Evotec Neurosciences GmbH
Richmond Pharmacology Limited

Completed

The Effects of a Novel NMDA NR2B-Subtype Selective Antagonist, EVT 101, on Brain Function

Human Volunteers

United Kingdom
King's College London
Queen Mary University of London; University of Liverpool

Completed

Snack Foods and Their Impact on Gastrointestinal Microbiology, Function and Symptoms (OptiGut)

Eating Behavior | Human Microbiome

United Kingdom
Quadram Institute Bioscience

Enrolling by invitation

The QIB Colon Model

Human Gut Microbiota

United Kingdom
Quadram Institute Bioscience
The Danish Council for Strategic Research

Completed

Effects of Brassica on Human Gut Lactobacilli (EBL)

Human Gut Microbiota

United Kingdom
Cancer Research UK

Completed

Phase I Study of MOv18 IgE

Human Cancers

United Kingdom
Public Health England

Completed

Observational Follow up of Prior HPV Vaccinees (HPVfollowup)

Human Papillomavirus Virus

United Kingdom
Cambridge University Hospitals NHS Foundation Trust
University of Cambridge

Completed

The Feasibility of Drug Delivery to Infants During Breastfeeding (FEDD)

Breast Feeding | Milk, Human | Infant, Newborn | Medication Systems

United Kingdom
Vaccitech (UK) Limited
University of Oxford

Completed

A Study to Determine the Safety and Immunogenicity of the Candidate Influenza Vaccine MVA-NP+M1

Human Volunteers

United Kingdom
University of Derby

Unknown

Investigation Into the Infectivity Levels of Human Papilloma Virus (HPV) in Tonsillar Tissue

Human Papillomavirus, Palatine Tonsil

United Kingdom
University of Aberdeen
Kellogg Company

Completed

Bioactive Phytochemicals From Wheat Bran (WB2001)

Bio-availability of Wheat Bran Phytochemicals in the Human Gut | Bio-availability of Wheat Bran Phytochemicals for the Systemic Circulation

United Kingdom
ViiV Healthcare
GlaxoSmithKline

Completed

Absolute Bioavailability of BMS-626529 After Oral and Intravenous Dosing

Infection, Human Immunodeficiency Virus

United Kingdom
University College, London
Public Health England

Completed

Specific Respiratory Infections as Triggers of Acute Medical Events

Cardiovascular Diseases | Influenza, Human | Respiratory Syncytial Virus Infections | Adenovirus | Rhinovirus | Parainfluenza | Human Metapneumovirus Pneumonia

United Kingdom
ViiV Healthcare
GlaxoSmithKline

Completed

Bioavailability of BMS-626529 in Healthy Subjects From Prototype Low Dose Extended Release Formulations (Part 1) and Prototype Extended Release Multi-particulate Formulations (Part 2) of BMS-663068 Relative to 600 mg Extended Release Tablet

Infection, Human Immunodeficiency Virus

United Kingdom
ViiV Healthcare
GlaxoSmithKline

Completed

Relative Bioavailability Study With BMS-955176

Infection, Human Immunodeficiency Virus

United Kingdom
NHS Blood and Transplant
Irish Blood Transfusion Service; Welsh Blood Service; Scottish National Blood...

Completed

Notification of Donors With Positive Microbiology Markers

Hepatitis B | Hepatitis C | Human Immunodeficiency Virus | Creutzfeldt-Jakob Syndrome | Human T-lymphotropic Virus I & II

United Kingdom
University of East Anglia
University of Washington; Fred Hutchinson Cancer Center

Unknown

An Acute Human Intervention With Flavonoid to Investigate Absorption, Metabolism and Excretion (COB)

Pharmacokinetics of Flavonoids in Humans

United Kingdom
ViiV Healthcare
GlaxoSmithKline

Completed

GSK3640254 First Time in Human (FTIH) Study in Healthy Volunteers

HIV Infections | Infection, Human Immunodeficiency Virus

United Kingdom
Imperial College London
Sense Biodetection Limited

Unknown

Evaluation of a Single Use Point of Care Device for the Diagnosis of Respiratory Pathogens (SIMPLIFI)

Enterovirus Infections | Respiratory Syncytial Virus Infections | Human Influenza | Rhinoviral Infections | Metapneumovirus Infection | Parainfluenzae Viral Infections

United Kingdom
ViiV Healthcare

Completed

Study to Evaluate the Pharmacokinetics of an Oral Contraceptive Containing Levonorgestrel and Ethinyl Estradiol When Co-administered With GSK1265744 in Healthy Adult Female Subjects

Infections, Human Immunodeficiency Virus and Hepatitis

United Kingdom
University of Aberdeen
NHS Grampian

Recruiting

Scottish Advanced Fetal Research Study (SAFeR)

Life Style | Fetal Development | Human | Fetal Developmental Abnormality

United Kingdom
ViiV Healthcare
GlaxoSmithKline

Completed

Effect of Rifabutin on the Pharmacokinetics of Oral Cabotegravir in Healthy Subjects

HIV Infections | Infection, Human Immunodeficiency Virus

United Kingdom
Seqirus

Completed

A Study to Assess the Immunogenicity and Safety of CSL's 2013/2014 Formulation of Enzira® Vaccine in Healthy Volunteers

Influenza, Human

United Kingdom
Seqirus

Completed

A Study to Assess the Immunogenicity and Safety of CSL's 2012/2013 Formulation of Enzira® Vaccine in Healthy Volunteers

Influenza, Human

United Kingdom
University of Oxford
Emory University; VisMederi srl

Completed

ADITEC FLU 2 STUDY: Understanding the Genetics Basis for Immune Responses to Flu Vaccines in Children and Adults

Influenza

United Kingdom
AstraZeneca

Completed

Uptake of the Childhood Live Attenuated Influenza Vaccine (LAIV) and Influenza-related Healthcare Resource Use in England During the 2012 to 2022 Flu Seasons; a Retrospective, Observational Study in the CPRD and HES Databases (INOCULATE)

Influenza

United Kingdom
Seqirus

Completed

A Study to Assess the Immunogenicity and Safety of a Trivalent Influenza Vaccine Containing the 2013/2014 Formulation of Enzira® Vaccine in Healthy Volunteers

Influenza, Human

United Kingdom
Alios Biopharma Inc.

Completed

A Study of AL-794 to Evaluate the Safety, Tolerability, and Pharmacokinetics of Single and Multiple Doses, and the Antiviral Activity of Multiple Doses in an Influenza Challenge Study

Influenza

United Kingdom
University of Nottingham
Imperial College London; University College, London; Retroscreen Virology Ltd.

Withdrawn

Evaluating Modes of Influenza Transmission Between Humans

Influenza

United Kingdom
PepTcell Limited

Completed

Phase 1b Influenza Vaccine Study in Healthy Subjects

Influenza

United Kingdom
PowderMed

Completed

Study of the Ability of a Flu Vaccine to Prevent Flu Infection

Influenza

United Kingdom
GlaxoSmithKline

Completed

Assess the Risk of Solid Organ Transplant Rejection Following Vaccination With Pandemrix™ in UK

Influenza

United Kingdom
PepTcell Limited

Completed

Influenza Vaccine Challenge Study in Healthy Subjects

Influenza

United Kingdom
Cidara Therapeutics Inc.
Janssen Pharmaceuticals

Completed

The Effectiveness of CD388 to Prevent Flu in an Influenza Challenge Model in Healthy Adults

Influenza

United Kingdom
PepTcell Limited
National Institute of Allergy and Infectious Diseases (NIAID)

Completed

Efficacy of FLU-v in an H1N1 Influenza Human Challenge Model

Influenza

United Kingdom
GlaxoSmithKline
University of Surrey

Completed

Post-authorisation Passive Enhanced Safety Surveillance of Seasonal Influenza Vaccines: Pilot Study in England

Influenza, Human

United Kingdom
Crucell Holland BV
Retroscreen Virology Ltd.

Completed

Evaluation of the Protective Efficacy and Safety of CR8020 in an Influenza Challenge

Influenza

United Kingdom
GlaxoSmithKline
University of Surrey

Completed

Post-authorisation Passive Enhanced Safety Surveillance of Seasonal Influenza Vaccines

Influenza, Human

United Kingdom
Biota Scientific Management Pty Ltd
National Institute of Allergy and Infectious Diseases (NIAID)

Completed

CS-8958 Single Inhaled Dose in Elderly

Influenza

United Kingdom
Public Health England
Royal Free and University College Medical School

Completed

Response of Older Adults to Influenza Vaccination With Regard to Cytomegalovirus (CMV) Status (CMVflu)

Influenza

United Kingdom
Biota Scientific Management Pty Ltd
National Institute of Allergy and Infectious Diseases (NIAID)

Completed

Safety, Tolerability and Pharmacokinetic Study of Biota-CS-8958

Influenza

United Kingdom
Autoimmune Technologies, LLC
National Institute of Allergy and Infectious Diseases (NIAID)

Completed

Safety and Protective Efficacy of FF-3 Dry Powder in Healthy Subjects Infected With Influenza Challenge Strain

Influenza

United Kingdom
Novartis
Novartis Vaccines

Withdrawn

Safety and Immunogenicity of a Commercially Available Influenza Vaccine (Formulation 2006/2007) When Administered to Subjects 18 Years of Age or Older

Influenza

United Kingdom
Novartis Vaccines

Completed

Immunogenicity of a Surface Antigen, Inactivated Influenza Vaccine Formulation 2007-2008

Influenza

United Kingdom
Hvivo

Completed

Influenza Challenge Study in Healthy Volunteers

Influenza

United Kingdom
University of Oxford

Completed

A Phase I Study to Determine the Safety and Immunogenicity of the Candidate Influenza Vaccine ChAdOx1-NP+M1

Influenza

United Kingdom
University of Oxford

Completed

A Study to Determine the Safety and Immunogenicity of Co-administration of the Candidate Influenza Vaccine MVA-NP+M1 and Seasonal Influenza Vaccine

Influenza

United Kingdom
Theraclone Sciences, Inc.

Unknown

Influenza Virus Challenge Study to Test Monoclonal Antibody TCN-032 as a Treatment for Influenza

Influenza

United Kingdom
University Hospitals, Leicester
Public Health England; Novartis Vaccines

Completed

Safety and Immunogenicity of A/H1N1v Vaccines in Healthy Adults

Influenza

United Kingdom

Clinical Trials on Babesiosis, Human in United Kingdom

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in South Korea

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations